Patient Characteristics and Disease Modifying Therapy use in Patients with Late Onset Multiple Sclerosis: A 30-year Retrospective Review

被引：0
|
作者：
Ahmad, S. [1 ]
Perez-Giraldo, G. [2 ]
Caldito, N. Gonzalez [2 ]
Grebenciucova, E. [2 ]
Balabanov, R. [2 ]
Cohen, B. [2 ]
Graham, E. L. [2 ]
机构：
[1] Univ Nevada, Kirk Kerkorian Sch Med, Las Vegas, NV USA
[2] Northwestern Univ, Dept Neurol Div Multiple Sclerosis & neuroimmunol, Chicago, IL USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P472
引用
收藏
页码：236 / 236
页数：1
相关论文
共 50 条
  • [1] Disease modifying therapy use in multiple sclerosis patients with comorbidities
    Conway, D. S.
    Planchon, S. M.
    Ontaneda, D.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 878 - 878
  • [2] Clinical characteristics and use of disease modifying therapy in the nationwide Danish cohort of paediatric onset multiple sclerosis
    Erdal, Julie Laub
    Kopp, Tine Iskov
    Blinkenberg, Morten
    Petersen, Thor
    Sorensen, Per Soelberg
    Magyari, Melinda
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 37
  • [3] Characteristics and Predictive Factors of Disability Outcomes of Multiple Sclerosis Patients with 5-Year Use of Initial Disease Modifying Therapy
    Mihai, Cornelia
    Teter, Barbara
    Apatoff, Brian
    Coyle, Patricia
    Gauthier, Susan
    Goodman, Andrew
    Gottesman, Malcolm
    Granger, Carl
    Herbert, Joseph
    Lawn, Fair
    Holub, Richard
    Jubelt, Burk
    Kister, Ilya
    Krupp, Lauren
    Lenihan, Michael
    Lublin, Fred
    Miller, Aaron
    Munschauer, Fredrick
    Perel, Allan
    Schwid, Steven
    Snyder, David
    Tullman, Mark
    Zivadinov, Robert
    Weinstock-Guttman, Bianca
    NEUROLOGY, 2009, 72 (11) : A82 - A82
  • [4] Disease modifying therapy in the aging multiple sclerosis patient
    Corboy, J. R.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 83 - 83
  • [5] Efficacy and Tolerability of Disease Modifying Therapies in Late Onset Multiple Sclerosis
    Thakolwiboon, Smathorn
    Karukote, Amputch
    Sohn, GyeongMo
    Jin, Dongkwan
    Avila, Mirla
    NEUROLOGY, 2020, 94 (15)
  • [6] A retrospective claims analysis of fatigue in patients with multiple sclerosis on disease-modifying therapy
    Leist, Thomas P.
    Cole, Michele
    Verma, Sumit
    Keenan, Alex
    Le, Hoa H.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 78
  • [7] An Update on the Use of Disease-Modifying Therapy in Pregnant Patients with Multiple Sclerosis
    Vaughn, Caila
    Bushra, Aisha
    Kolb, Channa
    Weinstock-Guttman, Bianca
    CNS DRUGS, 2018, 32 (02) : 161 - 178
  • [8] An Update on the Use of Disease-Modifying Therapy in Pregnant Patients with Multiple Sclerosis
    Caila Vaughn
    Aisha Bushra
    Channa Kolb
    Bianca Weinstock-Guttman
    CNS Drugs, 2018, 32 : 161 - 178
  • [9] Stopping Disease Modifying Therapy in Multiple Sclerosis Patients
    Presas, Silvia
    Vicente Hervas-Garcia, Jose
    Ramo-Tello, Cristina
    NEUROLOGY, 2016, 86
  • [10] Epidemiology and disease characteristics of late-onset Multiple Sclerosis
    Magyari, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 39 - 39
12345